RT Book, Section
A1 Newman, Jonathan D.
A1 Maron, David J.
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146606683
T1 Guideline-Directed Medical Therapy for Patients with Stable Ischemic Heart Disease
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146606683
RD 2024/04/20
AB Guideline-directed  medical  therapy  (GDMT)  is  an  intrinsic  part  of  management  of  patients  with  stable  ischemic  heart  disease  (SIHD)  whether  or  not  revascularization  is  performed.  GDMT  for  patients  with  coronary  disease  is  synonymous  with  secondary  prevention  and  consists  of  pharmacologic  and  lifestyle  interventions.  This  chapter  synthesizes  the  evidence  base  behind  guideline-recommended  therapies  for  secondary  prevention.  Outside  of  the  use  of  aspirin,  we  will  not  discuss  strategies  of  antiplatelet  therapy  for  post-percutaneous  coronary  intervention  (PCI)  patients,  which  are  reviewed  elsewhere.  Additionally,  management  of  anginal  symptoms  is  outside  the  scope  of  this  chapter,  and  angina  management  in  patients  with  SIHD  will  be  discussed  only  briefly  in  the  context  of  other  targets  for  secondary  prevention  and  risk  factor  modification.  We  will  begin  by  reviewing  the  GDMT  targets  for  risk  factor  modification  in  the  2012  SIHD  guidelines.1  Following  this,  we  will  review  the  other  medical  therapies  that  have  been  shown  to  prevent  death  and  myocardial  infarction  (MI)  among  patients  with  SIHD.